Recent Updates
Recently added Catalysts
MMSI Positive Sentiment

Merit Medical Announces Process for Chief Executive Officer Succession Planning

Key Takeaway: Merit Medical Systems, Inc. has announced its ongoing succession planning for the CEO role, as Founder and CEO Fred Lampropoulos will remain in position until December 31, 2025. A special steering committee of independent directors has been established to oversee the development of this succession plan, aided by Korn Ferry to identify potential candidates. The committee emphasizes the importance of finding a successor who can uphold Merit’s culture while driving innovation and growth.
Price reaction · baseline $71.56 (2023-12-15 close) · 1 other MMSI headline(s) in the window, move may be shared
day 0 close
-0.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • Merit Medical is proactively planning for its leadership transition.
  • The appointment of a special steering committee indicates a structured approach to succession.
  • The process is aimed at maintaining company culture and supporting future growth.

Full Press Release Details

SOUTH JORDAN, Utah, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today outlined the ongoing succession planning process for its Chief Executive Officer (CEO). Pursuant to an Amended and Restated Employment Agreement, effective June 8, 2023, Merit founder, CEO, and President, Fred Lampropoulos, will continue to serve as Merit’s CEO and President through December 31, 2025.
To carry out its responsibility for CEO succession, the Merit Board of Directors appointed a special steering committee of independent directors led by Ann Millner, Ed.D., Lead Independent Director. The committee is developing and providing oversight of a succession plan in preparation for Mr. Lampropoulos’ retirement. The plan is also intended to prepare the company for a CEO transition at the appropriate time. Korn Ferry, a leading executive search firm, is currently assisting Merit’s Board of Directors in the process of identifying potential internal and external candidates.
“My fellow directors and I are committed to identifying a successor with the capabilities inherent to Merit’s leadership requirements, including the ability to identify and pursue new strategic opportunities, attract and retain key talent, and build on the tradition of innovation that has been a hallmark of the company’s success,” said Dr. Millner. “We are focused on implementing a thoughtfully developed CEO succession plan that will maintain valued aspects of Merit’s culture and position the company for future growth, development, and value creation.”
The company does not intend to provide further updates on the process until such time as a successor is designated.
ABOUT MERIT MEDICAL Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force and clinical support team totaling more than 700 individuals. Merit employs approximately 7,100 people worldwide.
TRADEMARKS Unless noted otherwise, trademarks and registered trademarks used in this release are the property of Merit Medical Systems, Inc., its subsidiaries, or its licensors.
+1-801-432-2864 | sarah.comstock@merit.com
Mike Piccinino, CFA, IRC

Frequently Asked Questions

Who is the current CEO of Merit Medical Systems?

Fred Lampropoulos is the current CEO and President of Merit Medical.

What is the timeline for CEO succession at Merit Medical?

Fred Lampropoulos will remain CEO until December 31, 2025.

Who is leading the CEO succession planning at Merit Medical?

Ann Millner, Ed.D., is leading the special steering committee for succession.

What firm is assisting with the CEO succession process?

Korn Ferry is assisting in identifying potential CEO candidates.

When will updates on the succession process be provided?

No updates will be shared until a successor is designated.

Last updated: Dec 18, 2023